Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients

Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is revolutionizing the management of brain metastases (BMs). This study was to explore the value of upfront cranial radiotherapy (RT) in EGFR-mutated non-small cell lung cancer (NSCLC) with BMs compared with EGFR-TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xiao-Jing, Pan, Su-Ming, Lai, Shu-Zhen, Xu, Xiao-Nan, Deng, Mei-Ling, Wang, Xiao-Hui, Yao, Dun-Chen, Wu, Shao-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299879/
https://www.ncbi.nlm.nih.gov/pubmed/30619745
http://dx.doi.org/10.3389/fonc.2018.00603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299879/
https://www.ncbi.nlm.nih.gov/pubmed/30619745
http://dx.doi.org/10.3389/fonc.2018.00603

Ejemplares similares